Your session is about to expire
← Back to Search
Prehabilitation for Tricuspid Regurgitation
N/A
Waitlist Available
Research Sponsored by Baylor Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4-5 days (day 1 to day 4 of prehab or day of surgical intervention)
Awards & highlights
No Placebo-Only Group
Summary
This study will aim to standardize the prehabilitation protocol to optimize patients and document the clinical and echo variables that could improve clinical outcomes of tricuspid valve intervention.
Eligible Conditions
- Tricuspid Valve Disease
- Tricuspid Regurgitation
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 4-5 days (day 1 to day 4 of prehab or day of surgical intervention)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4-5 days (day 1 to day 4 of prehab or day of surgical intervention)
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in Nutritional Status
Change in Severity of Tricuspid Regurgitation by Echocardiographic assessment
Change in volume status according to daily input/outputs
+1 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: PrehabilitationExperimental Treatment1 Intervention
All study patients will receive preoperative optimization with a standardized prehabilitation protocol prior to any intervention.
Find a Location
Who is running the clinical trial?
Baylor Research InstituteLead Sponsor
206 Previous Clinical Trials
203,416 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger